|
related topics |
{stock, price, share} |
{regulation, government, change} |
{cost, contract, operation} |
{acquisition, growth, future} |
{stock, price, operating} |
{personnel, key, retain} |
{provision, law, control} |
{loss, insurance, financial} |
{interest, director, officer} |
{capital, credit, financial} |
{competitive, industry, competition} |
{product, liability, claim} |
|
We have liquidity problems and are uncertain of our continued access to loans.
Our ability to operate as a going concern is in doubt
Our business strategy depends on business collaborations.
Our previously reported losses could increase due to our inability to accurately estimate the overall risks, revenue, or costs on a contract.
We may continue to encounter difficulties in pursuing our growth objectives.
The U.S. government can audit and disallow claims for compensation under our government contracts, and can terminate those contracts without cause.
Most of our government contracts are awarded through a regulated competitive bidding process. The inability to complete existing government contracts or win new government contracts over an extended period could harm our operations and adversely affect our future revenues.
If our partners fail to perform their contractual obligations on a project, we could be exposed to legal liability, loss of reputation and profit reduction or loss on the project.
Our services expose us to significant risks of liability and our insurance policies may not provide adequate coverage.
We operate in a highly regulated industry requiring our customers and us to have and comply with federal, state, and local government permits and approvals.
Changes in existing environmental laws, regulations, and programs could reduce demand for our environmental services, which could cause our revenues to decline.
We face increasing competition in the provision of environmental services and waste treatment technologies.
Our success depends on attracting and retaining qualified personnel in a competitive environment.
Certain anti-takeover provisions and potential adverse effect on market price of securities from issuance of preferred stock may limit the ability of security holders to dispose of their shares if the anti-takeover provisions were enacted.
Our charter contains authorized, unissued preferred stock that may inhibit a change of control of our company under circumstances that could give shareholders an opportunity to realize a premium over prevailing market prices of our securities.
The value of our common stock could continue to be volatile
Our quarterly operating results may fluctuate significantly, which could have a negative effect on the price of our common stock.
Potential exercises of convertible instruments, warrants and options may adversely affect the market price of securities due to future sales of common stock
Future sales of our common stock may have a depressive effect on the market price of our stock
Our stock price could decline due to sales of shares issued upon conversion of the Series J Convertible Preferred Stock or the New Shaar Note or by short sales.
Full 10-K form ▸
|
|
related documents |
777491--2/27/2006--CH2M_HILL_COMPANIES_LTD |
822418--3/5/2008--BIO_IMAGING_TECHNOLOGIES_INC |
1340095--4/13/2007--Glenrose_Instruments_Inc. |
822418--3/29/2007--BIO_IMAGING_TECHNOLOGIES_INC |
857728--3/3/2006--I_FLOW_CORP_/DE/ |
822418--3/5/2009--BIO_IMAGING_TECHNOLOGIES_INC |
1035092--3/16/2007--SHORE_BANCSHARES_INC |
2186--3/14/2006--RELM_WIRELESS_CORP |
1086939--3/17/2008--NOVAMED_INC |
2186--3/7/2007--RELM_WIRELESS_CORP |
2186--3/5/2008--RELM_WIRELESS_CORP |
1086939--3/16/2009--NOVAMED_INC |
1086939--3/16/2010--NOVAMED_INC |
75439--3/31/2009--CytoCore_Inc |
1340095--3/31/2008--GlenRose_Instruments_Inc. |
1007330--3/23/2006--PRG_SCHULTZ_INTERNATIONAL_INC |
95366--1/13/2009--SUNAIR_SERVICES_CORP |
1088000--3/28/2006--ESSENTIAL_GROUP_INC |
357108--1/15/2008--IRVINE_SENSORS_CORP/DE/ |
763907--3/12/2008--FIRST_UNITED_CORP/MD/ |
851520--2/24/2010--EXPONENT_INC |
777491--2/23/2007--CH2M_HILL_COMPANIES_LTD |
1117414--5/29/2007--PBSJ_CORP_/FL/ |
96057--10/4/2006--SYS |
777491--2/25/2010--CH2M_HILL_COMPANIES_LTD |
1089473--3/16/2006--VENTIV_HEALTH_INC |
1089473--2/28/2007--INVENTIV_HEALTH_INC |
1099132--4/9/2010--MANHATTAN_SCIENTIFICS_INC |
857728--3/17/2008--I_FLOW_CORP_/DE/ |
351017--3/27/2008--AUTOINFO_INC |
|